Proqr Therapeutics Nv Share Price Today
(NASDAQ: PRQR)

Name: Proqr Therapeutics Nv Share Price Today (NASDAQ: PRQR) - Proqr Therapeutics Nv Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Proqr Therapeutics Nv share price is $2.04 & ₹177.42 as on 6 Mar 2025, 2.30 'hrs' IST

$2.04

▲

0.02

(0.99%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Proqr Therapeutics Nv share price in Dollar and Rupees. Guide to invest in Proqr Therapeutics Nv stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Proqr Therapeutics Nv, along with analyst recommendations, forecasts, and comprehensive financials.

Proqr Therapeutics Nv share price movements

Today's Low: $2.01
Today's High: $2.14
$2.04
1.47%
Downside
Day's Volatility :5.85%
Upside
4.45%
52 Weeks Low: $1.61
52 Weeks High: $4.62
$2.04
21.08%
Downside
52 Weeks Volatility :65.15%
Upside
55.84%

Proqr Therapeutics Nv (PRQR) Returns

Period	Proqr Therapeutics Nv	Sector (Health Care)	Index (Russel 2000)
3 Months	-42.94%	2.1%	0.0%
6 Months	7.16%	-4.1%	0.0%
1 Year	6.88%	2.2%	0.0%
3 Years	117.18%	11.8%	-11.6%

Proqr Therapeutics Nv (PRQR) Key Statistics

in dollars & INR

Previous Close	$2.02
Open	$2.04
Today's High	$2.135
Today's Low	$2.01
Market Capitalization	$225.6M
Today's Volume	$81.6K
52 Week High	$4.62
52 Week Low	$1.61
Revenue TTM	$18.4M
EBITDA	$-28.6M
Earnings Per Share (EPS)	$-0.32
Profit Margin	-130.21%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-67.14%

How to invest in Proqr Therapeutics Nv Stock (PRQR) from India?

It is very easy for Indian residents to invest directly in Proqr Therapeutics Nv from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Proqr Therapeutics Nv stock in both Indian Rupees (INR) and US Dollars (USD). Search for Proqr Therapeutics Nv or PRQR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Proqr Therapeutics Nv or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Proqr Therapeutics Nv shares which would translate to 0.426 fractional shares of Proqr Therapeutics Nv as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Proqr Therapeutics Nv, in just a few clicks!

Returns in Proqr Therapeutics Nv (PRQR) for Indian investors in Rupees

The Proqr Therapeutics Nv stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Proqr Therapeutics Nv investment value today

Current value as on today

₹1,12,899

Returns

₹12,899

(+12.9%)

Returns from Proqr Therapeutics Nv Stock

₹7,937 (+7.94%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Proqr Therapeutics Nv (PRQR)

33%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Proqr Therapeutics Nv Stock from India on INDmoney has increased by 33% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Proqr Therapeutics Nv

Adage Capital Partners Gp LLC
9.07%
Privium Fund Management B.V.
4.71%
Woodline Partners LP
3.36%
Millennium Management LLC
2.67%
Affinity Asset Advisors, LLC
2.67%
UBS Group AG
2.18%

Analyst Recommendation on Proqr Therapeutics Nv

Buy

84%Buy

15%Hold

0%Sell

Based on 13 Wall street analysts offering stock ratings for Proqr Therapeutics Nv(by analysts ranked 0 to 5 stars)

Based on 13 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Proqr Therapeutics Nv Stock (PRQR)

What analysts predicted

Upside of 362.19%

Target:

$9.43

Current:

$2.04

Insights on Proqr Therapeutics Nv Stock (Ticker Symbol: PRQR)

Price Movement
In the last 7 days, PRQR stock has moved down by -15.8%
Decreasing Revenue
Revenue is down for the last 2 quarters, 6.33M → 3.84M (in $), with an average decrease of 39.4% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -2.69M → -8.10M (in $), with an average decrease of 201.2% per quarter
PRQR vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 56.0%
Price to Sales
ForPRQR every $1 of sales, investors are willing to pay $8.9, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

PRQR Proqr Therapeutics Nv Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$5.6M	↓ 423.15%
Net Income	$-42.0M	↓ 15.45%
Net Profit Margin	-746.69%	↓ 3600.65%

	FY19	Y/Y Change
Revenue	$2.1M	↓ 60.88%
Net Income	$-63.1M	↑ 53.81%
Net Profit Margin	-2.9K%	↓ 2188.95%

	FY20	Y/Y Change
Revenue	$295.6K	↓ 87.43%
Net Income	$-56.7M	↓ 17.86%
Net Profit Margin	-19.2K%	↓ 16247.08%

	FY21	Y/Y Change
Revenue	$1.5M	↑ 457.2%
Net Income	$-69.7M	↑ 32.32%
Net Profit Margin	-4.6K%	↑ 14627.33%

	FY22	Y/Y Change
Revenue	$4.3M	↑ 198.15%
Net Income	$-68.7M	↑ 5.21%
Net Profit Margin	-1.6K%	↑ 2947.98%

	FY23	Y/Y Change
Revenue	$7.1M	↑ 61.36%
Net Income	$-30.7M	↓ 56.67%
Net Profit Margin	-431.67%	↑ 1175.74%

	Q2 FY23	Q/Q Change
Revenue	$1.3M	↑ 83.97%
Net Income	$-8.7M	↑ 0.03%
Net Profit Margin	-663.32%	↑ 556.68%

	Q3 FY23	Q/Q Change
Revenue	$1.5M	↑ 13.69%
Net Income	$-6.1M	↓ 28.56%
Net Profit Margin	-416.79%	↑ 246.53%

	Q4 FY23	Q/Q Change
Revenue	$3.5M	↑ 133.56%
Net Income	$-5.8M	↓ 6.44%
Net Profit Margin	-166.96%	↑ 249.83%

	Q1 FY24	Q/Q Change
Revenue	$4.9M	↑ 39.89%
Net Income	$-8.4M	↑ 44.19%
Net Profit Margin	-172.09%	↓ 5.13%

	Q2 FY24	Q/Q Change
Revenue	$6.8M	↑ 41.57%
Net Income	$-2.9M	↓ 65.05%
Net Profit Margin	-42.48%	↑ 129.61%

	Q3 FY24	Q/Q Change
Revenue	$3.8M	↓ 39.36%
Net Income	$-8.1M	↑ 201.19%
Net Profit Margin	-210.98%	↓ 168.5%

	FY18	Y/Y Change
Profit	$5.6M	↓ 423.15%

	FY19	Y/Y Change
Profit	$-127.7M	↓ 2425.24%

	FY20	Y/Y Change
Profit	$-2.7M	↓ 98.09%

	FY21	Y/Y Change
Profit	$1.5M	↓ 161.71%

	FY22	Y/Y Change
Profit	$1.7M	↑ 15.32%

	FY23	Y/Y Change
Profit	$7.0M	↑ 308.64%

	Q2 FY23	Q/Q Change
Profit	$1.3M	↑ 83.97%

	Q3 FY23	Q/Q Change
Profit	$1.5M	↑ 13.69%

	Q4 FY23	Q/Q Change
Profit	$3.5M	↑ 133.56%

	Q1 FY24	Q/Q Change
Profit	$4.1M	↑ 18.17%

	Q2 FY24	Q/Q Change
Profit	$6.0M	↑ 48.69%

	Q3 FY24	Q/Q Change
Profit	$3.8M	↓ 31.65%

	FY18	Y/Y Change
Operating Cash Flow	$-34.9M	↓ 12.21%
Investing Cash Flow	$-354.9K	↑ 157.85%
Financing Cash Flow	$100.8M	↑ 232.76%

	FY19	Y/Y Change
Operating Cash Flow	$-48.9M	↑ 43.31%
Investing Cash Flow	$-644.5K	↑ 85.9%
Financing Cash Flow	$55.8M	↓ 43.37%

	FY20	Y/Y Change
Operating Cash Flow	$-57.2M	↑ 7.03%
Investing Cash Flow	$-1.1M	↑ 59.31%
Financing Cash Flow	$17.6M	↓ 71.11%

	FY21	Y/Y Change
Operating Cash Flow	$-29.4M	↓ 44.73%
Investing Cash Flow	$-480.4K	↓ 54.0%
Financing Cash Flow	$154.7M	↑ 843.67%

	FY22	Y/Y Change
Operating Cash Flow	$-72.5M	↑ 163.37%
Investing Cash Flow	$-742.9K	↑ 65.18%
Financing Cash Flow	$-32.7M	↓ 122.58%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-11.2M	↓ 123.13%
Investing Cash Flow	$-318.9K	↑ 0.0%
Financing Cash Flow	$-697.5K	↑ 148.26%

Proqr Therapeutics Nv Technicals Summary

Sell

Neutral

Buy

Proqr Therapeutics Nv is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Proqr Therapeutics Nv (PRQR) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Proqr Therapeutics Nv	-8.18%	7.16%	6.88%	117.18%	-72.25%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Proqr Therapeutics Nv	NA	NA	0.0	-0.48	-0.67	-0.15	NA	0.31
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Proqr Therapeutics Nv	Buy	$225.6M	-72.25%	NA	-130.21%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Proqr Therapeutics Nv

ProQR Therapeutics N.V., a biotechnology company, focuses on the discovery and development of novel therapeutic medicines. The company's products pipeline includes AX-0810 for cholestatic diseases targeting Na-taurocholate cotransporting polypeptide (NTCP); and AX-1412 for cardiovascular diseases (CVDs) targeting Beta-1,4-galactosyltransferase 1 (B4GALT1). It also develops various other early-stage research programs, including AX-1005 for undisclosed targets in CVDs; AX-2402, which focuses on Rett syndrome; AX-2911 for nonalcoholic steatohepatitis (NASH); AX-0601 for obesity and Type 2 diabetes; and AX-9115 for rare metabolic condition, as well as various other targets. In addition, the company develops Axiomer RNA base-editing platform technology. It has a license agreement with Radboud University Medical Center; Inserm Transfert SA; Ionis Pharmaceuticals, Inc.; Vico Therapeutics B.V.; University of Rochester; and Leiden University Medical Center, as well as license and research collaboration with Eli Lilly and Company for the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system. The company was incorporated in 2012 and is headquartered in Leiden, the Netherlands.

Organization	Proqr Therapeutics Nv
Employees	156
CEO	Mr. Daniel Anton de Boer
Industry	Health Technology

Management People of Proqr Therapeutics Nv

Name	Title
Mr. Daniel Anton de Boer	Founder, CEO & Member of Management Board
Dr. Domenico Valerio Ph.D.	Founder & Independent Member of Supervisory Board
Mr. Rene K. Beukema	Chief Corporate Development Officer, General Counsel & Member of Management Board
Dr. Gerard Platenburg	Co-Founder, Chief Scientific Officer & Member of Management Board
Mr. Jurriaan Dekkers	Chief Financial Officer
Ms. Sheila Sponselee	Chief People & Operations Officer
Ms. Sarah Cue Kiely	Vice President of Investor Relations & Corporate Communications
Ms. Sandra van der Kolk	Junior Financial Controller

Important FAQs about investing in PRQR Stock from India :

What is Proqr Therapeutics Nv share price today?

Proqr Therapeutics Nv share price today stands at $2.04, Open: $2.04 ; Previous Close: $2.02 ; High: $2.14 ; Low: $2.01 ; 52 Week High: $4.62 ; 52 Week Low: $1.61.

The stock opens at $2.04, after a previous close of $2.02. The stock reached a daily high of $2.14 and a low of $2.01, with a 52-week high of $4.62 and a 52-week low of $1.61.

Can Indians buy Proqr Therapeutics Nv shares?

Yes, Indians can invest in the Proqr Therapeutics Nv (PRQR) from India.

With INDmoney, you can buy Proqr Therapeutics Nv at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Proqr Therapeutics Nv at zero transaction cost.

How can I buy Proqr Therapeutics Nv shares from India?

It is very easy to buy Proqr Therapeutics Nv from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Proqr Therapeutics Nv (PRQR) be purchased?

Yes, you can buy fractional shares of Proqr Therapeutics Nv with INDmoney app.

What are the documents required to start investing in Proqr Therapeutics Nv stocks?

To start investing in Proqr Therapeutics Nv, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.